Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 3
2003 2
2007 1
2008 1
2009 1
2010 1
2011 1
2012 1
2014 1
2015 3
2016 1
2017 2
2018 1
2020 1
2021 1
2022 1
2023 2
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Effects of Liberal vs Restrictive Transfusion Thresholds on Survival and Neurocognitive Outcomes in Extremely Low-Birth-Weight Infants: The ETTNO Randomized Clinical Trial.
Franz AR, Engel C, Bassler D, Rüdiger M, Thome UH, Maier RF, Krägeloh-Mann I, Kron M, Essers J, Bührer C, Rellensmann G, Rossi R, Bittrich HJ, Roll C, Höhn T, Ehrhardt H, Avenarius S, Körner HT, Stein A, Buxmann H, Vochem M, Poets CF; ETTNO Investigators. Franz AR, et al. Among authors: avenarius s. JAMA. 2020 Aug 11;324(6):560-570. doi: 10.1001/jama.2020.10690. JAMA. 2020. PMID: 32780138 Free PMC article. Clinical Trial.
Early postnatal high-dose fat-soluble enteral vitamin A supplementation for moderate or severe bronchopulmonary dysplasia or death in extremely low birthweight infants (NeoVitaA): a multicentre, randomised, parallel-group, double-blind, placebo-controlled, investigator-initiated phase 3 trial.
Meyer S, Bay J, Franz AR, Ehrhardt H, Klein L, Petzinger J, Binder C, Kirschenhofer S, Stein A, Hüning B, Heep A, Cloppenburg E, Muyimbwa J, Ott T, Sandkötter J, Teig N, Wiegand S, Schroth M, Kick A, Wurm D, Gebauer C, Linnemann K, Kittel J, Wieg C, Kiechl-Kohlendorfer U, Schmidt S, Böttger R, Thomas W, Brevis Nunez F, Stockmann A, Kriebel T, Müller A, Klotz D, Morhart P, Nohr D, Biesalski HK, Giannopoulou EZ, Hilt S, Poryo M, Wagenpfeil S, Haiden N, Ruckes C, Ehrlich A, Gortner L; NeoVitaA trial investigators. Meyer S, et al. Lancet Respir Med. 2024 Jul;12(7):544-555. doi: 10.1016/S2213-2600(24)00073-0. Epub 2024 Apr 18. Lancet Respir Med. 2024. PMID: 38643780 Clinical Trial.
Assessment of Retinopathy of Prematurity Regression and Reactivation Using an Artificial Intelligence-Based Vascular Severity Score.
Eilts SK, Pfeil JM, Poschkamp B, Krohne TU, Eter N, Barth T, Guthoff R, Lagrèze W, Grundel M, Bründer MC, Busch M, Kalpathy-Cramer J, Chiang MF, Chan RVP, Coyner AS, Ostmo S, Campbell JP, Stahl A; Comparing Alternative Ranibizumab Dosages for Safety and Efficacy in Retinopathy of Prematurity (CARE-ROP) Study Group. Eilts SK, et al. JAMA Netw Open. 2023 Jan 3;6(1):e2251512. doi: 10.1001/jamanetworkopen.2022.51512. JAMA Netw Open. 2023. PMID: 36656578 Free PMC article. Clinical Trial.
Similar adverse outcome rates with high or low oxygen saturation targets in an area with low background mortality.
Willgerodt N, Bührer C, Rossi R, Kühn T, Rüdiger M, Avenarius S, Böttger R, Olbertz DM, Proquitte H, Bittrich HJ, Haase R, Fröhlich M, Höhne S, Thome UH. Willgerodt N, et al. Among authors: avenarius s. Front Pediatr. 2023 Oct 24;11:1235877. doi: 10.3389/fped.2023.1235877. eCollection 2023. Front Pediatr. 2023. PMID: 37941976 Free PMC article.
Less invasive surfactant administration is associated with improved pulmonary outcomes in spontaneously breathing preterm infants.
Göpel W, Kribs A, Härtel C, Avenarius S, Teig N, Groneck P, Olbertz D, Roll C, Vochem M, Weller U, von der Wense A, Wieg C, Wintgens J, Preuss M, Ziegler A, Roth B, Herting E; German Neonatal Network (GNN). Göpel W, et al. Among authors: avenarius s. Acta Paediatr. 2015 Mar;104(3):241-6. doi: 10.1111/apa.12883. Acta Paediatr. 2015. PMID: 25474712 Clinical Trial.
Permissive hypercapnia in extremely low birthweight infants (PHELBI): a randomised controlled multicentre trial.
Thome UH, Genzel-Boroviczeny O, Bohnhorst B, Schmid M, Fuchs H, Rohde O, Avenarius S, Topf HG, Zimmermann A, Faas D, Timme K, Kleinlein B, Buxmann H, Schenk W, Segerer H, Teig N, Gebauer C, Hentschel R, Heckmann M, Schlösser R, Peters J, Rossi R, Rascher W, Böttger R, Seidenberg J, Hansen G, Zernickel M, Alzen G, Dreyhaupt J, Muche R, Hummler HD; PHELBI Study Group. Thome UH, et al. Among authors: avenarius s. Lancet Respir Med. 2015 Jul;3(7):534-43. doi: 10.1016/S2213-2600(15)00204-0. Epub 2015 Jun 15. Lancet Respir Med. 2015. PMID: 26088180 Clinical Trial.
Influence of PCO2 Control on Clinical and Neurodevelopmental Outcomes of Extremely Low Birth Weight Infants.
Thome UH, Dreyhaupt J, Genzel-Boroviczeny O, Bohnhorst B, Schmid M, Fuchs H, Rohde O, Avenarius S, Topf HG, Zimmermann A, Faas D, Timme K, Kleinlein B, Buxmann H, Schenk W, Segerer H, Teig N, Ackermann B, Hentschel R, Heckmann M, Schlösser R, Peters J, Rossi R, Rascher W, Böttger R, Seidenberg J, Hansen G, Bode H, Zernickel M, Muche R, Hummler HD; PHELBI Study Group. Thome UH, et al. Among authors: avenarius s. Neonatology. 2018;113(3):221-230. doi: 10.1159/000485828. Epub 2018 Jan 4. Neonatology. 2018. PMID: 29298438 Free article.
24 results